Kaiser Health News is releasing years of Purdue Pharma's internal budget documents to offer insight into the hundreds of millions of dollars spent to launch and promote OxyContin.

As the nations bill for drug and genetic tests has climbed to an estimated $8.5 billion a year, theres mounting suspicion among health insurers that some testing may do more to boost profit margins than help treat patients.